Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital

BACKGROUND: Bevacizumab vials that are commercially available are fractionated into smaller quantities into the form of pre-filled syringes in a sterile and aseptic laboratory setting. PURPOSE: To share the long term experience of aliquoting of bevacizumab injections in a tertiary eye care center in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramesh, Santosh, Sivaranjani, S, Hasmukhbhai, Nirav Zala, Yadav, Divya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
IJO Videos
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332976/
https://www.ncbi.nlm.nih.gov/pubmed/35502117
http://dx.doi.org/10.4103/ijo.IJO_1016_22
_version_ 1784758778789363712
author Ramesh, Santosh
Sivaranjani, S
Hasmukhbhai, Nirav Zala
Yadav, Divya
author_facet Ramesh, Santosh
Sivaranjani, S
Hasmukhbhai, Nirav Zala
Yadav, Divya
author_sort Ramesh, Santosh
collection PubMed
description BACKGROUND: Bevacizumab vials that are commercially available are fractionated into smaller quantities into the form of pre-filled syringes in a sterile and aseptic laboratory setting. PURPOSE: To share the long term experience of aliquoting of bevacizumab injections in a tertiary eye care center in India. SYNOPSIS: Compounding of bevacizumab was found to be a cost-effective and sustainable practice that has benefited more patients with an affordable cost, while maintaining high levels of quality. HIGHLIGHTS: Compounding of bevacizumab, when done with aseptic precautions can be a safe and cost-effective practice, the benefits of which can be passed on to needful patients. VIDEO LINK: https://youtu.be/C5XOpKHFkew
format Online
Article
Text
id pubmed-9332976
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93329762022-07-29 Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital Ramesh, Santosh Sivaranjani, S Hasmukhbhai, Nirav Zala Yadav, Divya Indian J Ophthalmol IJO Videos BACKGROUND: Bevacizumab vials that are commercially available are fractionated into smaller quantities into the form of pre-filled syringes in a sterile and aseptic laboratory setting. PURPOSE: To share the long term experience of aliquoting of bevacizumab injections in a tertiary eye care center in India. SYNOPSIS: Compounding of bevacizumab was found to be a cost-effective and sustainable practice that has benefited more patients with an affordable cost, while maintaining high levels of quality. HIGHLIGHTS: Compounding of bevacizumab, when done with aseptic precautions can be a safe and cost-effective practice, the benefits of which can be passed on to needful patients. VIDEO LINK: https://youtu.be/C5XOpKHFkew Wolters Kluwer - Medknow 2022-05 /pmc/articles/PMC9332976/ /pubmed/35502117 http://dx.doi.org/10.4103/ijo.IJO_1016_22 Text en Copyright: © 2022 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle IJO Videos
Ramesh, Santosh
Sivaranjani, S
Hasmukhbhai, Nirav Zala
Yadav, Divya
Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_full Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_fullStr Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_full_unstemmed Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_short Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_sort power of compounding intravitreal bevacizumab - experience from a tertiary eye care hospital
topic IJO Videos
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332976/
https://www.ncbi.nlm.nih.gov/pubmed/35502117
http://dx.doi.org/10.4103/ijo.IJO_1016_22
work_keys_str_mv AT rameshsantosh powerofcompoundingintravitrealbevacizumabexperiencefromatertiaryeyecarehospital
AT sivaranjanis powerofcompoundingintravitrealbevacizumabexperiencefromatertiaryeyecarehospital
AT hasmukhbhainiravzala powerofcompoundingintravitrealbevacizumabexperiencefromatertiaryeyecarehospital
AT yadavdivya powerofcompoundingintravitrealbevacizumabexperiencefromatertiaryeyecarehospital

Ejemplares similares